273 related articles for article (PubMed ID: 22253142)
21. "A Bayesian sensitivity analysis to evaluate the impact of unmeasured confounding with external data: a real world comparative effectiveness study in osteoporosis".
Zhang X; Faries DE; Boytsov N; Stamey JD; Seaman JW
Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):982-92. PubMed ID: 27396534
[TBL] [Abstract][Full Text] [Related]
22. Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
de Peuter OR; Lip GY; Souverein PC; Klungel OH; de Boer A; Büller HR; Kamphuisen PW
Eur J Heart Fail; 2011 May; 13(5):489-95. PubMed ID: 21193438
[TBL] [Abstract][Full Text] [Related]
23. Bayesian analysis for generalized linear models with nonignorably missing covariates.
Huang L; Chen MH; Ibrahim JG
Biometrics; 2005 Sep; 61(3):767-80. PubMed ID: 16135028
[TBL] [Abstract][Full Text] [Related]
24. Bayesian propensity score analysis for observational data.
McCandless LC; Gustafson P; Austin PC
Stat Med; 2009 Jan; 28(1):94-112. PubMed ID: 19012268
[TBL] [Abstract][Full Text] [Related]
25. The concept of the marginally matched subject in propensity-score matched analyses.
Austin PC; Lee DS
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):469-82. PubMed ID: 19319923
[TBL] [Abstract][Full Text] [Related]
26. Bias Formulas for Estimating Direct and Indirect Effects When Unmeasured Confounding Is Present.
le Cessie S
Epidemiology; 2016 Jan; 27(1):125-32. PubMed ID: 26426943
[TBL] [Abstract][Full Text] [Related]
27. Just the berries. Management of heart failure.
Ruggles L
Can Fam Physician; 2001 Mar; 47():499-501. PubMed ID: 11281082
[No Abstract] [Full Text] [Related]
28. Should three-drug therapy be standard for heart failure?
Harv Heart Lett; 1999 Jan; 9(5):5-6. PubMed ID: 9916561
[No Abstract] [Full Text] [Related]
29. Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research.
Johnston KM; Gustafson P; Levy AR; Grootendorst P
Stat Med; 2008 Apr; 27(9):1539-56. PubMed ID: 17847052
[TBL] [Abstract][Full Text] [Related]
30. Treatment of systolic heart failure in the elderly: an evidence-based review.
Arif SA; Mergenhagen KA; Del Carpio RO; Ho C
Ann Pharmacother; 2010 Oct; 44(10):1604-14. PubMed ID: 20841514
[TBL] [Abstract][Full Text] [Related]
31. Bias formulas for external adjustment and sensitivity analysis of unmeasured confounders.
Arah OA; Chiba Y; Greenland S
Ann Epidemiol; 2008 Aug; 18(8):637-46. PubMed ID: 18652982
[TBL] [Abstract][Full Text] [Related]
32. [Practical aspects of diagnosis, treatment and prognosis in chronic heart failure].
Wagdi P
Dtsch Med Wochenschr; 1999 Mar; 124(10):291-5. PubMed ID: 10191824
[No Abstract] [Full Text] [Related]
33. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer.
Steenland K; Greenland S
Am J Epidemiol; 2004 Aug; 160(4):384-92. PubMed ID: 15286024
[TBL] [Abstract][Full Text] [Related]
34. Replication of the Scandinavian Simvastatin Survival Study using a primary care medical record database prompted exploration of a new method to address unmeasured confounding.
Weiner MG; Xie D; Tannen RL
Pharmacoepidemiol Drug Saf; 2008 Jul; 17(7):661-70. PubMed ID: 18327857
[TBL] [Abstract][Full Text] [Related]
35. Community management of heart failure.
McKelvie RS
Can Fam Physician; 1998 Dec; 44():2689-92, 2695-8. PubMed ID: 9870122
[TBL] [Abstract][Full Text] [Related]
36. [Combination therapy of beta blockers for heart failure].
Watanabe M; Hirata Y
Nihon Rinsho; 2007 May; 65 Suppl 5():129-33. PubMed ID: 17571376
[No Abstract] [Full Text] [Related]
37. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk.
Sciarretta S; Palano F; Tocci G; Baldini R; Volpe M
Arch Intern Med; 2011 Mar; 171(5):384-94. PubMed ID: 21059964
[TBL] [Abstract][Full Text] [Related]
38. Concomitant use of a positive inotropic agent to create a bridge to the successful initiation of beta-blocker therapy in patients with heart failure: a proposal for a trial.
Zampino M; O'Connor CM; Gattis WA; Adams KF; Gheorghiade M
Am Heart J; 2003 Feb; 145(2 Suppl):S62-6. PubMed ID: 12594456
[No Abstract] [Full Text] [Related]
39. The treatment of heart failure in the elderly patient with comorbidities.
Briscoe TA; Earle SR; Lob MK; Somerville LL
Director; 2004; 12(1):36-41. PubMed ID: 19178116
[No Abstract] [Full Text] [Related]
40. [Progress in medical treatment of heart failure].
López Mora E
Arch Cardiol Mex; 2001; 71 Suppl 1():S95-101. PubMed ID: 11565355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
